Associated Papers
Effects of pathological mutations on the CHCHD2 monomer structure: A study by AlphaFold3 linked to the generation of conformational ensembles.
Özmen ZA et al.
Computers in Biology and Medicine, 2025
Role of the mitochondrial regulatory factor CHCHD2 in neurodegenerative diseases.
Guo X et al.
Frontiers in Neuroscience, 2025
Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
Ren YL et al.
Molecular Neurobiology, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Westenberger A et al.
Brain : a Journal of Neurology, 2024
Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
Torii S et al.
Embo Molecular Medicine, 2023
Genetic Movement Disorders Commonly Seen in Asians.
Jagota P et al.
Movement Disorders Clinical Practice, 2023
Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.
Jia F et al.
Genes, 2022
CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder.
Jiang T et al.
Frontiers in Neuroscience, 2022
Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?
Ikeda A et al.
Frontiers in Cell and Developmental Biology, 2022
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
Kee TR et al.
Frontiers in Aging Neuroscience, 2021
Association of rare variants in neurodegenerative genes with familial Alzheimer's disease.
Zhang W et al.
Annals of Clinical and Translational Neurology, 2020
Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
Zhou W et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry, 2020
Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma.
Diefenbach RJ et al.
Cancers, 2019
PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Zhou W et al.
Human Molecular Genetics, 2019
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Imai Y et al.
International Journal of Molecular Sciences, 2019
Early-onset Parkinson disease caused by a mutation in CHCHD2 and mitochondrial dysfunction.
Lee RG et al.
Neurology. Genetics, 2018
Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X et al.
Molecular Medicine Reports, 2018
Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.
Zhou ZD et al.
Molecular Neurobiology, 2017
Pathophysiologic effects of CHCHD2 variants associated with late-onset Parkinson disease.
Kim JM
Human Mutation, 2017
Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
Rubino E et al.
Neurobiology of Aging, 2017
Mutational analysis of CHCHD2 in Chinese patients with multiple system atrophy and amyotrophic lateral sclerosis.
Yang X et al.
Journal of the Neurological Sciences, 2016
Mutation analysis of the CHCHD2 gene in Chinese Han patients with Parkinson's disease.
Lu Q et al.
Parkinsonism & Related Disorders, 2016
CHCHD2 gene mutations in familial and sporadic Parkinson's disease.
Shi CH et al.
Neurobiology of Aging, 2016